Biosensors International offers interventional devices and solutions for patients living with Coronary Artery Disease with a track record and continued innovation in the development of next-generation medical technologies, that make a difference to patients’ lives around the world.

Pioneering spirit led to Biosensors International developing its own Proprietary Technology in Biolimus A9™. The only limus drug designed specifically for coronary stent applications. BA9™ coated DES and DCS platforms, started a new stent generation that provides treatment solutions for previously neglected patients.

In the cardiovascular arena, Biosensors International is focused on the development, manufacture and commercialization of drug-eluting stents, drug coated stents and bare metal stents as well as angioplasty catheters for the treatment of coronary artery disease

PRODUCTS:

BioMatrix Alpha: The innovative hybrid Cobalt-Chromium Abluminal Biodegradable Polymer DES

BioMatrix™ Alpha presents the best in class stent platform design with unique pro-healing coating from the pioneer in abluminal biodegradable technology.

It combines the proven safety of a DES with an abluminal biodegradable polymer, the proven efficacy of BA9™ and an innovative cobalt-chromium stent platform design.

BioFreedom Ultra: Polymer- and carrier-free Drug Coated Stent with BA9™

The combination of a selectively micro-structured abluminal surface (SMS) and Biolimus A9™ make BioFreedom™ Ultra a unique stent for HBR patients.

Powerline: Semi-compliant balloon catheter

The advanced catheter technology of Powerline™ is designed to offer the right balance of PUSH, TRACK and CROSS to ensure optimal balloon placement and expansion.

The MultiPleat™ folding technology is designed to facilitate the treatment of multiple lesions as the machine folding provides a more consistent rewrap of the balloon.

Rise: Non-compliant balloon catheter

RISE™ NC’s deliverability and durability will accompany physicians in even the most challenging cases.

New Valve Technology (NVT) Allegra TAVI System:

The ALLEGRA™ TAVI System TF is a catheter-based transfemoral heart valve system. It is indicated for the treatment of severe calcified aortic valve stenosis in high risk patients with elevated surgical risk or in patients with a symptomatic degeneration of an aortic valve bioprosthesis.